Fibroblast activation protein inhibitor (FAPI) PET-CT is an evolving imaging technology that has showed promising results in the diagnosis, staging, and monitoring of a variety of cancers. It is a revolutionary molecular imaging technology that targets and binds to the fibroblast activation protein, which is overexpressed in many cancer cells.
Evolving breakthrough in cancer imaging Ga-68 FAPI PET-CT Scan
This technology detects and visualises cancer cells in the body by injecting a small quantity of radioactive FAPI tracer into the patient’s bloodstream. This imaging technology can detect tumours with low glucose metabolism, resulting in fewer false-negative results.
Why Choose Ga-68 FAPI PET-CT Scan
FAPI PET-CT has several potential benefits over other diagnostic imaging techniques:
Reduced ambiguity in cancer imaging / staging in cases where the tumour is less sensitive / undetectable to FDG scan
Improved sensitivity & specificity in certain cancer diagnosis and staging
Personalized Treatment Planning
Why Choose Ga-68 FAPI PET-CT Scan
FAPI PET-CT has several potential benefits over other diagnostic imaging techniques:
Reduced ambiguity in cancer imaging / staging in cases where the tumour is less sensitive / undetectable to FDG scan
Improved sensitivity & specificity in certain cancer diagnosis and staging
Personalized Treatment Planning
What is a Ga-68 FAPI PET-CT scan
GA 68 FAPI PET-CT is a nuclear medicine imaging technology that produces images of the body using a positron-emitting radionuclide.
The patient is injected with a radioactive tracer that binds to FAP, which is overexpressed in the stroma of numerous types of cancers, and then undergoes PET-CT imaging.
The PET scanner detects the positrons released by the radioactive tracer and generates 3D images of the body that a nuclear medicine physician can view and analyse.
What is a Ga-68 FAPI PET-CT used for
| Ga-68 FAPI PET-CT has been demonstrated to be useful in diagnosing, staging, and monitoring a variety of malignancies. | Ga-68 FAPI PET-CT has been demonstrated to be more sensitive than FDG PET-CT in diagnosing specific types of cancer and it has the potential to be used to predict therapy response and monitor treatment efficacy. |
What is a Ga-68 FAPI PET-CT used for
Ga-68 FAPI PET-CT has been demonstrated to be useful in diagnosing, staging, and monitoring a variety of malignancies.
Ga-68 FAPI PET-CT has been demonstrated to be more sensitive than FDG PET-CT in diagnosing specific types of cancer and it has the potential to be used to predict therapy response and monitor treatment efficacy.
GA 68 FAPI PET-CT is a promising imaging tool for diagnosing and monitoring cancer that are non-FDG avid, with outstanding target-to-background contrast ratios and the ability to offer vital information about the tumour microenvironment. As research in this area continues, GA 68 FAPI PET-CT is expected to become an increasingly important tool in cancer imaging and treatment.
Schedule An Appointment Today
More Contact Information
Email:
info@beaconhospital.com.my
Whatsapp:
+6012 328 6913
Office Hour:
Monday – Friday,
8:30 AM – 6:00 PM
Chat with our Medical Enquiry Team.
